Literature DB >> 28966361

Hypocholesterolemia and nonregenerative, suspected immune-mediated, anemia: Report of 3 canine cases.

Rachel Robbins1, Katrina R Viviano1.   

Abstract

This report describes hypocholesterolemia in 3 dogs with nonregenerative, suspected immune-mediated anemias. Common causes of hypocholesterolemia were ruled out, raising suspicion for a mechanistic link between anemia and hypocholesterolemia in dogs. As observed in humans with concurrent anemia and hypocholesterolemia, cholesterol concentrations increased to within the reference interval once the dogs' anemia resolved.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28966361      PMCID： PMC5603918     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


  20 in total

1.  Oxidative status and plasma lipid profile in β-thalassemia patients.

Authors:  Nassima Boudrahem-Addour; Malika Izem-Meziane; Khadidja Bouguerra; Nassima Nadjem; Nadia Zidani; Meriem Belhani; Bahia Djerdjouri
Journal:  Hemoglobin       Date:  2014-11-14       Impact factor: 0.849

2.  Hypocholesterolemia in Nigerian children with sickle cell disease.

Authors:  Dorothy J VanderJagt; Jaimie Shores; Anthony Okorodudu; Seline N Okolo; Robert H Glew
Journal:  J Trop Pediatr       Date:  2002-06       Impact factor: 1.165

Review 3.  Stress erythropoiesis: new signals and new stress progenitor cells.

Authors:  Robert F Paulson; Lei Shi; Dai-Chen Wu
Journal:  Curr Opin Hematol       Date:  2011-05       Impact factor: 3.284

4.  Hypocholesterolemia in chronic anemias with increased erythropoietic activity.

Authors:  Hanna Shalev; Joseph Kapelushnik; Asher Moser; Hilla Knobler; Hannah Tamary
Journal:  Am J Hematol       Date:  2007-03       Impact factor: 10.047

5.  Hypocholesterolemia in children and adolescents with beta-thalassemia intermedia.

Authors:  Corina Hartman; Hannah Tamary; Ada Tamir; Evelyn Shabad; Carina Levine; Ariel Koren; Raanan Shamir
Journal:  J Pediatr       Date:  2002-10       Impact factor: 4.406

6.  The clinical and biologic significance of abnormal lipid profiles in patients with myelodysplastic syndromes.

Authors:  K Allampallam; D Dutt; C Nair; V Shetty; S Mundle; L Lisak; C Andrews; B Ahmed; L Mazzone; F Zorat; R Borok; M Muzammil; A Gundroo; I Ansaarie; A Raza
Journal:  J Hematother Stem Cell Res       Date:  2000-04

7.  Treatment of nonregenerative anemia with human gamma-globulin in dogs.

Authors:  J C Scott-Moncrieff; W J Reagan; L T Glickman; D B DeNicola; D Harrington
Journal:  J Am Vet Med Assoc       Date:  1995-06-15       Impact factor: 1.936

8.  beta-Thalassaemia and factors affecting the metabolism of lipids and lipoproteins.

Authors:  D A Papanastasiou; T Siorokou; F A Haliotis
Journal:  Haematologia (Budap)       Date:  1996

9.  Plasma and erythrocyte lipids in hereditary spherocytosis.

Authors:  R Johnsson; N E Saris
Journal:  Clin Chim Acta       Date:  1981-08-10       Impact factor: 3.786

10.  Serum lipoprotein profile in the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency.

Authors:  S Muntoni; B Batetta; S Dessi; S Muntoni; P Pani
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.